Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Traits
Traits linked to MT-ND4
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4
The Human Phenotype Ontology links 144 traits to MT-ND4, by body system: features seen in people with one of the gene's rare conditions.
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Abnormality of the nervous system
Abnormality of the eye
| Trait | How often it is seen |
|---|---|
| Slow decrease in sharpness of vision | Very often (80–99%) |
| Blind spot located at fixation point | Often (30–79%) |
| Blurred vision | Often (30–79%) |
| Centrocecal scotoma | Often (30–79%) |
| Damaged optic nerve | Often (30–79%) |
| Optic atrophy | Often (30–79%) |
| Pigmentary retinopathy | Often (30–79%) |
| Progressive loss of vision | Often (30–79%) |
| Visual loss | Often (30–79%) |
| Weakness of muscles controlling eye movement | Often (30–79%) |
| Abnormal color vision | Sometimes (5–29%) |
| Abnormal electroretinogram | Sometimes (5–29%) |
| Abnormality of visual evoked potentials | Sometimes (5–29%) |
| Involuntary, rapid, rhythmic eye movements | Sometimes (5–29%) |
| Progressive external ophthalmoplegia | Sometimes (5–29%) |
| Reduced contrast sensitivity | Sometimes (5–29%) |
| Retinal nerve fiber edema | Sometimes (5–29%) |
| Rod-cone dystrophy | Sometimes (5–29%) |
| Leber optic atrophy | Not recorded |
Laboratory abnormality
| Trait | How often it is seen |
|---|---|
| Abnormality of Krebs cycle metabolism | Very often (80–99%) |
| Higher than normal levels of lactate in blood | Very often (80–99%) |
| Increased CSF lactate | Very often (80–99%) |
| Increased lactate in body | Very often (80–99%) |
| Diabetes mellitus | Often (30–79%) |
| High urine lactic acid levels | Often (30–79%) |
| Increased CSF protein concentration | Often (30–79%) |
| Fever | Sometimes (5–29%) |
| High urine protein levels | Sometimes (5–29%) |
| Hypothermia | Sometimes (5–29%) |
| Increased blood alanine | Sometimes (5–29%) |
| Noninsulin-dependent diabetes | Sometimes (5–29%) |
| Type 1 diabetes | Sometimes (5–29%) |
| Decreased circulating citrulline concentration | Rarely (1–4%) |
Abnormality of the cardiovascular system
| Trait | How often it is seen |
|---|---|
| Stroke-like episode | Very often (80–99%) |
| Retinal telangiectasia | Often (30–79%) |
| Retinal vascular tortuosity | Often (30–79%) |
| Abnormal heart rate | Sometimes (5–29%) |
| Cardiac conduction abnormality | Sometimes (5–29%) |
| Concentric hypertrophic cardiomyopathy | Sometimes (5–29%) |
| Disease of the heart muscle | Sometimes (5–29%) |
| Enlarged and thickened heart muscle | Sometimes (5–29%) |
| Increased blood pressure in blood vessels of lungs | Sometimes (5–29%) |
| Redness of skin or mucous membrane | Sometimes (5–29%) |
| Stretched and thinned heart muscle | Sometimes (5–29%) |
| Ventricular preexcitation | Sometimes (5–29%) |
| Wolff-Parkinson-White syndrome | Sometimes (5–29%) |
Abnormality of the digestive system
| Trait | How often it is seen |
|---|---|
| Episodic vomiting | Often (30–79%) |
| Vomiting | Often (30–79%) |
| Constipation | Sometimes (5–29%) |
| Diarrhea | Sometimes (5–29%) |
| Enlarged liver | Sometimes (5–29%) |
| Gastrointestinal dysmotility | Sometimes (5–29%) |
| Intestinal pseudo-obstruction | Sometimes (5–29%) |
| Liver failure | Sometimes (5–29%) |
| Poor swallowing | Sometimes (5–29%) |
| Recurring pancreas inflammation | Sometimes (5–29%) |
Abnormality of the musculoskeletal system
| Trait | How often it is seen |
|---|---|
| Muscle weakness | Very often (80–99%) |
| Ragged-red muscle fibers | Very often (80–99%) |
| Basal ganglia calcification | Often (30–79%) |
| Decreased muscle tone in infant | Often (30–79%) |
| Involuntary muscle stiffness, contraction, or spasm | Often (30–79%) |
| Muscle tissue disease | Often (30–79%) |
| Spasticity and rigidity of muscles | Often (30–79%) |
| Mitochondrial myopathy | Sometimes (5–29%) |
Abnormality of the genitourinary system
| Trait | How often it is seen |
|---|---|
| Abnormal renal tubule morphology | Sometimes (5–29%) |
| Focal segmental glomerulosclerosis | Sometimes (5–29%) |
| Kidney damage | Sometimes (5–29%) |
| Multiple glomerular cysts | Sometimes (5–29%) |
| Proximal tubulopathy | Sometimes (5–29%) |
Abnormality of the respiratory system
| Trait | How often it is seen |
|---|---|
| Apnea | Sometimes (5–29%) |
| Breathing difficulty | Sometimes (5–29%) |
| Episodic difficulty breathing | Sometimes (5–29%) |
| Rapid breathing | Sometimes (5–29%) |
Abnormality of the endocrine system
| Trait | How often it is seen |
|---|---|
| Decreased parathyroid hormone secretion | Rarely (1–4%) |
| Hypogonadotropic hypogonadism | Rarely (1–4%) |
| Underactive thyroid | Rarely (1–4%) |
Abnormal cellular phenotype
| Trait | How often it is seen |
|---|---|
| Abnormal mitochondria in muscle tissue | Very often (80–99%) |
| Mitochondrial respiratory chain defects | Very often (80–99%) |
Abnormality of the integument
| Trait | How often it is seen |
|---|---|
| Blotchy loss of skin color | Sometimes (5–29%) |
| Excessive hair growth | Sometimes (5–29%) |
Growth abnormality
| Trait | How often it is seen |
|---|---|
| Faltering weight | Often (30–79%) |
| Short stature | Often (30–79%) |
Abnormality of blood and blood-forming tissues
| Trait | How often it is seen |
|---|---|
| Low number of red blood cells or hemoglobin | Sometimes (5–29%) |
Abnormality of head or neck
| Trait | How often it is seen |
|---|---|
| Central retinal vessel vascular tortuosity | Not recorded |
Abnormality of the ear
| Trait | How often it is seen |
|---|---|
| Sensorineural hearing impairment | Often (30–79%) |
Constitutional symptom
| Trait | How often it is seen |
|---|---|
| Decreased ability to exercise | Sometimes (5–29%) |
How often is among people with one of the gene's conditions, the most often across them, as the Human Phenotype Ontology records it. These pages describe traits and the research behind them; they are not a diagnosis, and a doctor or genetic counsellor is the person to ask about symptoms.
Where this comes from
- The Human Phenotype Ontology, release 2026-09-01: the traits linked to MT-ND4 and how often each is seen. Find out more at hpo.jax.org.
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
One test. A lifetime of answers.
From $449Free shipping · Results in 6–8 weeks